Necrostatin-1 blocks both RIPK1 and IDO: consequences for the study of cell death in experimental disease models

nork Vandenabeele, P, Grootjans, S, Callewaert, N, Takahashi, N
Argitaratua 2013

Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models

nork Takahashi, N, Duprez, L, Grootjans, S, Cauwels, A, Nerinckx, W, DuHadaway, J B, Goossens, V, Roelandt, R, Van Hauwermeiren, F, Libert, C, Declercq, W, Callewaert, N, Prendergast, G C, Degterev, A, Yuan, J, Vandenabeele, P
Argitaratua 2012

Multiple Phenotypes in Phosphoglucomutase 1 Deficiency

nork Tegtmeyer, L.C., Rust, S., van Scherpenzeel, M., Ng, B.G., Losfeld, M.-E., Timal, S., Raymond, K., He, P., Ichikawa, M., Veltman, J., Huijben, K., Shin, Y.S., Sharma, V., Adamowicz, M., Lammens, M., Reunert, J., Witten, A., Schrapers, E., Matthijs, G., Jaeken, J., Rymen, D., Stojkovic, T., Laforêt, P., Petit, F., Aumaître, O., Czarnowska, E., Piraud, M., Podskarbi, T., Stanley, C.A., Matalon, R., Burda, P., Seyyedi, S., Debus, V., Socha, P., Sykut-Cegielska, J., van Spronsen, F., de Meirleir, L., Vajro, P., DeClue, T., Ficicioglu, C., Wada, Y., Wevers, R.A., Vanderschaeghe, D., Callewaert, N., Fingerhut, R., van Schaftingen, E., Freeze, H.H., Morava, E., Lefeber, D.J., Marquardt, T.
Argitaratua izan da N Engl J Med (2014)